Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness
Authors:
- I. HoeferIHI. Hoefer
- J.P.G. SluijterJSJ.P.G. Sluijter
- J.D. LamanJLJ.D. Laman
- D.P.V. de KleijnDKD.P.V. de Kleijn
- G. PasterkampGPG. Pasterkamp
- 1 March 2008
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 197 (1) , 95-104
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Levels of extra domain A containing fibronectin in human atherosclerotic plaques are associated with a stable plaque phenotypeAtherosclerosis, 2007
- Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion developmentCardiovascular Research, 2005
- CD36 is a sensor of diacylglyceridesNature, 2005
- Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5Nature, 2004
- Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosisBlood, 2004
- HSP60 induces self‐tolerance to repeated HSP60 stimulation and cross‐tolerance to other pro‐inflammatory stimuliEuropean Journal of Immunology, 2004
- Involvement of IRAK-M in Peptidoglycan-induced Tolerance in MacrophagesJournal of Biological Chemistry, 2004
- Modulation of the Lipopolysaccharide Receptor Complex (CD14, TLR4, MD-2) and Toll-Like Receptor 2 in Systemic Inflammatory Response Syndrome-Positive Patients With and Without Infection: Relationship to ToleranceShock, 2003
- T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptorsThe FASEB Journal, 2003
- Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responsesTrends in Immunology, 2002